≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Disorders of puberty, all

Endpoint Browser

E4_DISPUB_ALL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E22.80, E22.88, E30
  • Hospital discharge: ICD-9 — 2590A|2591A|2531X
  • Cause of death: ICD-10 — E22.80, E22.88, E30
  • Cause of death: ICD-9 — 2590A|2591A|2531X

2 out of 7 registries used, show all original rules.

695

4. Check minimum number of events

None

695

5. Include endpoints

695

6. Filter based on genotype QC (FinnGen only)

695

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 695 453 242
Unadjusted period prevalence (%) 0.14 0.15 0.11
Median age at first event (years) 11.93 10.36 14.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
628
Matched controls
6282
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E30.1
ICD-10 Finland
Precocious puberty
2119.3
169.8
157
*
E30.09
ICD-10 Finland
Delayed puberty NOS
+∞
169.7
155
*
E30.00
ICD-10 Finland
Familial delayed puberty
+∞
162.8
149
*
E22.80
ICD-10 Finland
Central precocious puberty
+∞
98.6
92
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
12.4
94.3
183
201
E30.9
ICD-10 Finland
Disorder of puberty, unspecified
835.0
77.0
74
*
E30.8
ICD-10 Finland
Other disorders of puberty
733.7
68.3
66
*
L02AE02
ATC
leuprorelin; implant, parenteral
36.5
62.3
80
25
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
26.8
60.3
84
36
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
457.9
43.8
43
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
15.9
30.6
50
34
E34.35
ICD-10 Finland
Abnormal growth retardation
10.4
30.1
60
63
H01AC01
ATC
somatropin; parenteral
8.0
20.5
47
63
E22.88
ICD-10 Finland
Other hyperfunction of pituitary gland
+∞
19.9
19
*
2590A
ICD-9 Finland
Other endocrine disorders, Delay in sexual development and puberty, not elsewhere classified
+∞
19.9
19
*
2591A
ICD-9 Finland
Other endocrine disorders, Precocious sexual development and puberty, not elsewhere classified
+∞
19.9
19
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
13.3
16.3
28
22
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
8.6
14.9
32
39
121
Kela drug reimbursment
Severe hypofunction of sexual glands
14.9
14.1
23
16
H03AA01
ATC
levothyroxine sodium; systemic
2.7
14.0
106
445
L02AE04
ATC
triptorelin; parenteral
+∞
13.6
13
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
9.4
13.3
27
30
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
13.1
187
1066
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
19.5
13.0
19
10
E23.00
ICD-10 Finland
Panhypopituitarism
24.9
12.5
17
7
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.9
12.1
75
279
H02AB09
ATC
hydrocortisone; systemic
4.1
11.7
45
115
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
11.6
70
255
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
10.9
208
1309
Z3231
NOMESCO Finland
Registered nurse
1.9
10.8
203
1272
104
Kela drug reimbursment
Thyroid insufficiency
5.2
10.6
32
64
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
6.7
10.6
26
40
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
10.5
45
127
G03DB01
ATC
dydrogesterone; oral
3.0
10.5
60
211
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
8.1
10.2
22
28
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.0
10.1
59
211
E27.0
ICD-10 Finland
Other adrenocortical overactivity
10.3
10.1
19
19
N91.0
ICD-10 Finland
Primary amenorrhoea
10.9
9.8
18
17
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
9.8
81
357
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.1
9.6
54
187
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
7.3
9.6
22
31
E30.0
ICD-10 Finland
Delayed puberty
+∞
9.4
9
*
R1260
NOMESCO Finland
Evaluation of communicative skills
7.1
9.4
22
32
E34.45
ICD-10 Finland
Abnormal growth increase
13.9
9.2
15
11
Z3226
NOMESCO Finland
Physiotherapist
2.0
9.1
134
761
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.8
163
1004
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.4
8.6
30
71
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
2.6
8.4
63
262
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
8.2
83
403
602
Kela drug reimbursment
Children's severe malnutrition
3.9
8.2
32
85
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
8.1
110
602
T99
ICPC
Endocr/metab/nutrit disease other
10.2
8.1
15
15
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.2
8.0
29
72
F83
ICD-10 Finland
Mixed specific developmental disorders
3.5
7.5
33
97
E34.30
ICD-10 Finland
Short stature NOS
8.5
7.3
15
18
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.3
106
596
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
7.3
104
581
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
7.2
124
739
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.4
7.0
32
98
H47.2
ICD-10 Finland
Optic atrophy
14.0
6.9
11
8
H50.31
ICD-10 Finland
Intermittent exotropia
4.5
6.7
22
50
P05.1
ICD-10 Finland
Small for gestational age
7.9
6.6
14
18
ZXE00
NOMESCO Finland
One hour or less
1.6
6.5
230
1682
L04AA01
ATC
[U] ciclosporin; systemic
6.3
6.5
16
26
P85
ICPC
Mental retardation
7.5
6.4
14
19
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
6.3
93
524
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
11.2
6.3
11
10
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
+∞
6.3
6
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
6.3
101
587
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
6.2
89
497
Z2446
NOMESCO Finland
Social worker
1.9
6.2
87
481
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.1
160
1079
T10
ICPC
Growth delay
8.7
6.1
12
14
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.0
6.0
22
56
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
5.6
6.0
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009214) Lutropin [Units/volume] in Serum or Plasma
179
410
5.53
76.84
3.5
1.7
u/l
5.3
6.9
1.59
145
298
(3023323) Follitropin [Units/volume] in Serum or Plasma
165
388
5.27
68.17
3.4
1.7
iu/l
8.3
9.6
0.35
137
279
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
68
87
8.56
50.63
2.7
1.8
nmol/l
0.1
0.2
1.11
59
69
(3017446) Testosterone [Moles/volume] in Serum or Plasma
134
383
4.10
42.02
3.5
1.9
nmol/l
7.0
11.0
5.56
120
345
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
33
44
7.82
23.52
2.0
2.0
nmol/l
4.3
5.7
0.76
33
44
(3015377) Calcium [Moles/volume] in Serum or Plasma
208
1183
2.08
16.19
2.6
2.6
mmol/l
2.4
2.4
0.24
191
1067
(3035637) Corticotropin [Mass/volume] in Plasma
43
109
4.14
15.53
2.2
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
116
540
2.38
14.68
3.4
2.2
nmol/l
357.6
382.2
0.76
110
506
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
520
4166
1.99
13.65
4.9
3.7
pmol/l
14.4
14.4
0.10
488
3779
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
50
161
3.27
12.74
2.0
1.6
nmol/l
0.3
0.3
0.05
41
136
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
283
1917
1.80
12.38
10.0
7.7
mmol/l
1.2
1.2
1.01
246
1688
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
262
1769
1.77
11.36
9.9
7.8
mmol/l
1.2
1.2
0.53
248
1651
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
283
1998
1.70
10.19
3.5
2.8
nmol/l
69.7
67.3
0.79
266
1876
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
57
230
2.61
9.71
1.6
1.4
ug/l
7.5
4.0
1.14
51
217
(3021387) Prolactin [Units/volume] in Serum or Plasma
94
485
2.08
9.10
1.8
1.5
mu/l
427.6
324.5
1.07
88
427
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
15
8.12
8.88
2.3
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
556
4788
1.81
8.82
5.5
4.1
mu/l
2.1
2.0
0.04
533
4505
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
32
101
3.27
8.45
2.3
1.4
u/l
8.8
11.0
0.34
27
92
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
393
3143
1.58
7.84
7.5
5.5
u/l
94.5
87.2
1.42
371
2939
(3026782) Osmolality of Urine
147
923
1.75
7.78
3.9
2.7
mosm/kgh2o
632.2
590.2
1.03
131
798
(3024561) Albumin [Mass/volume] in Serum or Plasma
219
1530
1.63
7.76
6.3
5.6
g/l
37.7
38.2
0.72
206
1419
(3018418) pH of Serum or Plasma
158
1014
1.72
7.74
5.1
3.1
ph
7.4
7.4
0.67
41
192
(3023103) Potassium [Moles/volume] in Serum or Plasma
554
4824
1.73
7.73
13.2
8.9
mmol/l
3.9
3.9
0.58
533
4626
(3019550) Sodium [Moles/volume] in Serum or Plasma
553
4817
1.72
7.66
13.3
9.0
mmol/l
139.6
139.5
0.20
534
4640
(3000850) Epithelial cells [#/volume] in Urine
151
974
1.70
7.21
4.1
2.7
e6/l
5.5
8.4
2.29
129
843
(3021901) Oxygen saturation in Capillary blood
23
65
3.63
7.20
4.1
4.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
201
1409
1.60
6.89
8.1
7.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
220
1576
1.58
6.88
4.6
3.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
247
1818
1.56
6.86
1.6
1.6
g/l
1.9
1.9
0.03
124
1034
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
272
2050
1.54
6.76
1.5
1.6
u/ml
1.8
2.3
0.26
58
450
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
597
5367
1.80
6.74
9.9
7.4
u/l
28.0
25.9
0.99
581
5160
(3030467) Casts [#/volume] in Urine by Automated count
191
1331
1.60
6.69
4.1
3.2
e6/l
0.3
0.2
0.52
145
987
(3023368) Bacteria identified in Blood by Culture
126
810
1.68
6.03
4.7
3.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
98
591
1.77
5.89
10.8
9.8
mmol/l
25.3
24.9
0.56
98
591
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
249
1886
1.50
5.85
5.8
5.6
umol/l
9.8
10.7
1.04
234
1739
(21494814) CD8 cells/100 lymphocytes in Specimen
10
9
11.25
5.81
3.4
2.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
10
9
11.25
5.81
3.4
2.2
%
9.6
3.9
—
10
9
(36304419) Bacteria [Presence] in Urine
188
1349
1.54
5.67
4.1
3.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
76
429
1.87
5.67
9.5
6.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
17
5.95
5.64
3.4
2.5
e9/l
0.2
0.1
—
10
17
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
86
507
1.79
5.58
9.3
6.1
mmol/l
1.5
1.0
0.55
61
367
(3022096) Basophils/100 leukocytes in Blood
322
2590
1.45
5.48
9.7
7.6
%
0.6
0.6
0.76
311
2454
(3013650) Neutrophils [#/volume] in Blood by Automated count
378
3134
1.45
5.48
11.0
9.0
e9/l
3.9
3.7
0.54
334
2690
(3009343) pH of Capillary blood
86
510
1.78
5.47
9.4
6.1
ph
7.4
7.4
0.42
11
33
(3021589) Normoblasts [#/volume] in Blood
326
2635
1.45
5.37
10.7
8.8
e9/l
0.0
0.0
0.51
262
2083
(3007461) Platelets [#/volume] in Blood
667
6304
2.44
5.37
18.3
13.5
e9/l
265.3
263.5
0.28
644
6102
(36660697) Celiac disease serology panel - Serum
119
777
1.64
5.34
1.2
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
196
1438
1.51
5.28
4.5
3.2
e6/l
28.0
104.2
0.87
147
1079
(3024731) MCV [Entitic volume]
667
6311
2.41
5.23
18.3
13.4
fl
87.9
87.9
0.02
660
6217
(3035941) MCH [Entitic mass]
667
6312
2.41
5.21
18.3
13.3
pg
29.4
29.5
0.48
660
6219
(3026361) Erythrocytes [#/volume] in Blood
667
6313
2.40
5.19
18.3
13.4
e12/l
4.6
4.6
0.77
643
6098
(3017181) Myelocytes/100 leukocytes in Blood
61
330
1.93
5.18
6.9
4.7
%
0.9
0.8
0.14
18
77
(3001604) Monocytes [#/volume] in Blood
342
2803
1.43
5.16
9.3
7.4
e9/l
0.6
0.5
2.17
300
2417
(3002385) Erythrocyte distribution width [Ratio]
559
5037
1.56
5.11
16.2
11.9
%
13.2
13.1
1.62
550
4936
(3010813) Leukocytes [#/volume] in Blood
667
6318
2.38
5.09
18.4
13.4
e9/l
6.8
6.7
0.30
644
6107
(3000963) Hemoglobin [Mass/volume] in Blood
667
6319
2.38
5.07
18.5
13.6
g/l
134.9
136.1
1.64
660
6227
(40767503) Oxygen content in Capillary blood by calculation
21
71
3.02
5.02
3.3
3.1
%
18.2
17.7
0.22
15
38
(3006504) Eosinophils/100 leukocytes in Blood
329
2688
1.43
4.99
9.6
7.4
%
2.9
2.9
0.04
317
2535
(3019198) Lymphocytes [#/volume] in Blood
356
2954
1.42
4.93
9.1
7.2
e9/l
2.1
2.1
0.55
322
2604
(3006315) Basophils [#/volume] in Blood
341
2809
1.42
4.92
9.3
7.4
e9/l
0.0
0.0
0.07
302
2423
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
57
3.22
4.79
5.8
6.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
346
2868
1.41
4.76
9.4
7.1
%
32.0
32.4
0.21
334
2727
(3025159) Blasts/100 leukocytes in Blood
57
312
1.90
4.69
7.3
4.7
%
0.1
0.0
0.35
17
61
(3019069) Monocytes/100 leukocytes in Blood
329
2710
1.41
4.66
10.1
7.5
%
8.3
8.1
0.84
316
2573
(3013826) Glucose [Moles/volume] in Serum or Plasma
314
2568
1.41
4.63
5.7
4.8
mmol/l
6.4
6.1
0.76
287
2275
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
127
873
1.56
4.57
2.7
2.3
u/l
173.6
284.9
0.74
121
831
(42870588) Differential panel, method unspecified - Blood
245
1924
1.42
4.53
8.8
7.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
156
1124
1.50
4.52
4.2
4.6
inr
1.1
1.1
0.54
59
389
(3002032) Base excess in Venous blood by calculation
100
652
1.62
4.50
6.1
7.7
mmol/l
1.7
1.4
0.50
90
526
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
28
118
2.43
4.45
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
28
118
2.43
4.45
1.3
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
345
2884
1.39
4.39
10.1
7.8
e9/l
0.2
0.2
0.03
312
2524
(3018010) Neutrophils/100 leukocytes in Blood
337
2812
1.39
4.31
9.0
7.0
%
53.2
53.4
0.12
325
2683
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
27
114
2.42
4.28
2.0
1.6
pmol/l
118.5
196.5
2.37
27
107
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
450
3944
1.40
4.25
3.1
2.5
mmol/l
5.5
5.4
0.23
427
3632
(3002179) Metamyelocytes/100 leukocytes in Blood
56
316
1.84
4.22
5.8
4.2
%
0.5
0.5
0.01
13
58
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
452
3970
1.40
4.18
9.3
6.5
ml/min/173m2
109.2
106.6
1.56
341
2867
(3021440) Promyelocytes/100 leukocytes in Blood
56
319
1.82
4.10
7.4
4.7
%
0.1
0.1
0.15
17
71
(3018095) Leukocytes [#/volume] in Urine
228
1795
1.40
4.07
5.4
3.7
e6/l
43.4
67.4
0.71
153
1155
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
99
2.48
4.01
1.4
1.3
ug/g
290.5
366.0
—
10
43
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
590
5457
1.54
4.00
12.7
9.3
mg/l
18.5
21.1
1.28
454
3876
(3000991) Gas panel - Venous blood
89
581
1.61
3.98
9.9
9.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
228
1.94
3.92
3.3
2.5
ml/min/173m2
90.9
91.9
0.04
14
77
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
449
1.67
3.86
3.2
4.4
ng/l
247.0
954.5
1.27
55
346
(3003396) Base excess in Arterial blood by calculation
45
246
1.89
3.76
10.1
10.9
mmol/l
0.4
0.4
0.01
33
193
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
81
525
1.61
3.74
3.9
2.7
%
25.3
23.6
0.37
75
476
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
39
205
1.96
3.65
1.6
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
19
74
2.61
3.57
1.0
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
399
3481
1.34
3.57
5.0
3.8
mm/h
8.5
7.4
1.25
373
3207
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
63
390
1.68
3.48
1.8
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
161
1223
1.41
3.47
4.1
3.8
mmol/l
9.5
9.0
0.49
148
1104
(1616796) Gas panel - Central venous blood
23
100
2.34
3.46
6.3
4.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
198
1560
1.38
3.43
3.9
3.4
u/l
39.0
29.2
0.84
192
1478
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
27
3.74
3.36
1.5
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
63
394
1.66
3.36
1.8
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
88
599
1.54
3.31
2.0
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
15
54
2.82
3.27
4.2
1.8
mosm/kgh2o
292.9
295.9
0.26
15
46
(3012516) Albumin [Mass/volume] in Urine
85
576
1.54
3.26
4.5
3.9
mg/l
55.2
94.5
1.14
74
432
(3039000) Anion gap in Blood
12
38
3.20
3.22
5.0
16.8
mmol/l
12.8
11.1
0.72
12
29
(3026250) Tacrolimus [Mass/volume] in Blood
14
49
2.90
3.20
49.1
42.6
ug/l
6.5
6.9
0.37
14
44
(3013290) Carbon dioxide [Partial pressure] in Blood
21
91
2.35
3.20
5.8
4.1
kpa
5.3
4.8
2.20
21
91
(3012501) Base excess in Blood by calculation
21
91
2.35
3.20
5.8
4.0
mmol/l
1.6
2.0
0.46
15
46
(3027315) Oxygen [Partial pressure] in Blood
21
91
2.35
3.20
5.8
3.6
kpa
9.8
9.5
0.36
21
91
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
167
1296
1.38
3.15
1.6
1.5
pmol/l
91.2
97.2
1.04
83
723
(3018572) Chloride [Moles/volume] in Blood
12
39
3.11
3.10
5.0
16.4
mmol/l
103.4
105.4
0.36
12
30
(40761511) CBC panel - Blood by Automated count
603
5669
1.48
3.09
11.0
7.6
—
—
—
0
0
(4306422)
19
80
2.41
3.08
1.4
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
80
2.41
3.08
3.1
3.7
%
11.1
9.2
—
10
71
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
34
3.27
3.07
1.7
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
16
5.04
3.05
1.0
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
78
527
1.54
3.04
2.1
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
86
594
1.51
3.03
5.0
4.7
mg/mmol
7.4
13.4
1.20
76
445
(3026389) Candida sp identified in Specimen by Organism specific culture
19
81
2.38
3.01
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
51
2.78
3.00
4.0
5.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
65
425
1.58
2.92
3.9
3.9
g/l
0.2
0.2
0.62
65
406
(3026008) Bacteria identified in Urine by Culture
169
1334
1.35
2.85
2.6
2.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
77
2.37
2.84
3.3
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
71
2.43
2.82
1.1
1.7
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
14
53
2.68
2.81
3.5
2.8
u/ml
198.6
97.0
—
5
17
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
376
3318
1.29
2.80
4.3
3.2
mmol/mol
37.2
36.5
0.58
358
3123
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
153
1.93
2.74
2.8
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
70
473
1.53
2.74
4.5
3.2
g/l
10.8
10.2
0.65
63
439
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
41
242
1.74
2.73
2.3
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
49
304
1.66
2.73
4.4
4.3
e9/l
67.9
63.2
0.34
34
207
(3002173) Hemoglobin [Mass/volume] in Arterial blood
35
197
1.82
2.73
11.8
10.3
g/l
123.9
125.7
0.17
35
185
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
72
492
1.52
2.68
2.3
2.1
mmol/l
2.4
2.4
1.05
60
406
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
32
3.16
2.65
1.4
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
120
2.04
2.63
5.1
3.6
e9/l
3.3
3.6
0.26
24
120
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
49
2.68
2.63
1.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
105
777
1.41
2.61
2.8
2.8
e6/l
0.7
1.0
0.85
49
422
(3036489) Thrombin time
43
261
1.69
2.61
3.4
6.0
s
20.9
22.0
1.44
38
242
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
15
4.70
2.60
10.9
11.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
9
25
3.63
2.58
1.2
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
40
239
1.71
2.57
3.5
7.0
g/l
3.9
3.0
1.95
40
230
(3010421) pH of Blood
21
101
2.11
2.55
5.8
3.8
ph
7.4
7.4
0.07
21
91
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
11
5.49
2.55
1.0
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
153
1209
1.34
2.54
2.5
2.5
u/l
54.0
55.0
0.15
141
1114
(3040151) Glucose [Moles/volume] in Capillary blood
13
50
2.63
2.54
1.5
2.0
mmol/l
5.5
5.9
—
8
40
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
26
3.49
2.49
2.0
1.5
pg
34.9
32.4
—
9
26
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
123
1.99
2.48
5.3
3.8
%
50.3
53.0
0.44
24
123
(3004789) Transferrin [Mass/volume] in Serum or Plasma
82
586
1.45
2.46
3.8
2.6
g/l
2.5
2.6
0.17
76
534
(3003338) MCHC [Mass/volume]
564
5296
1.34
2.42
15.1
11.7
g/l
333.7
334.6
1.29
559
5235
(3022948) Iron [Moles/volume] in Serum or Plasma
88
640
1.43
2.41
3.7
2.6
umol/l
15.1
14.8
0.10
82
596
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
79
564
1.45
2.39
2.0
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
8
6.29
2.37
2.2
2.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
92
677
1.41
2.37
3.8
3.3
umol/l
312.7
2359.2
1.34
87
625
(3021960) Folate [Moles/volume] in Serum or Plasma
97
721
1.40
2.36
1.5
1.4
nmol/l
19.0
18.3
0.21
85
632
(3044640) Blood type and Crossmatch panel - Blood
170
1379
1.31
2.34
3.2
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
138
1087
1.34
2.34
3.0
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
594
5630
1.38
2.33
14.2
10.5
%
39.6
40.5
2.82
504
4805
(3003181) Sodium [Moles/volume] in Urine
12
47
2.58
2.28
6.9
2.3
mmol/l
101.0
77.1
0.98
12
41
(21494434) Karyotype in Bone marrow
8
23
3.51
2.27
1.4
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
100
2.03
2.22
1.5
1.2
u/ml
1.7
5.6
—
10
49
(3048689) Calprotectin [Mass/mass] in Stool
135
1069
1.33
2.21
3.0
2.8
ug/g
127.2
105.5
0.32
104
836
(21494815) CD4 cells/100 lymphocytes in Specimen
17
80
2.15
2.20
3.2
3.8
—
43.5
—
0
6
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
76
548
1.43
2.20
1.3
1.5
pmol/l
469.1
28571853.6
0.80
68
476
(3017143) Hepatitis C virus Ab [Presence] in Serum
143
1144
1.31
2.17
1.8
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
78
568
1.42
2.14
2.6
1.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
22
116
1.93
2.13
4.0
11.8
mmol/l
24.9
23.5
0.91
22
104
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
132
1.85
2.06
16.4
14.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
15
4.03
2.04
5.8
7.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
97
1.99
2.02
1.4
1.2
u/ml
3.0
4.2
—
9
50
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
8
26
3.10
2.02
4.3
6.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
26
3.10
2.02
4.3
6.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
76
558
1.41
2.00
1.3
1.2
iu/ml
118.5
149.3
0.31
24
203
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
99
761
1.35
1.98
3.1
2.8
e6/l
7.9
4.0
0.52
45
407
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
74
543
1.41
1.96
4.8
5.1
umol/l
5.0
7.0
1.03
65
437
(3031040) Bacteria [#/volume] in Urine by Automated count
370
3344
1.23
1.95
5.6
3.8
e6/l
15.0
418.3
—
6
30
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
16
3.77
1.94
3.8
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
33
2.75
1.93
10.1
8.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
51
350
1.49
1.91
1.6
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
61
434
1.44
1.91
1.7
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
8
28
2.88
1.86
1.4
1.0
u/l
190.4
147.4
—
8
20
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
230
1.60
1.85
1.4
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
17
3.55
1.84
4.0
3.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
116
1.84
1.80
3.6
8.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
47
2.36
1.78
3.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
274
2420
1.22
1.76
2.7
2.3
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
6
18
3.35
1.75
3.0
2.8
ug/g
184.3
167.3
—
6
18
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
299
1.50
1.75
3.6
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
36
2.52
1.74
3.9
1.5
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
24
2.94
1.72
5.1
6.9
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
8
31
2.60
1.66
8.5
2.4
mmol/l
22.8
34.7
—
8
31
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
25
2.82
1.65
3.3
5.1
ug/l
162.7
152.4
—
7
25
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
11
49
2.26
1.64
1.5
1.5
pmol/l
329.3
387.8
—
6
42
(3025941) Bacteria identified in Stool by Culture
48
338
1.45
1.62
1.4
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
14
3.59
1.62
1.4
1.1
ml
2506.0
2523.2
—
5
14
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
157
1319
1.25
1.61
2.7
2.6
mg/l
2.7
2.5
0.51
130
1142
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
20
3.02
1.58
4.5
5.8
ug/l
14.1
22.3
—
6
20
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
26
2.71
1.58
2.1
1.6
nmol/l
24.5
1.1
—
7
20
(40768443) Skin Pathology biopsy report
22
129
1.73
1.58
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
11
50
2.22
1.57
4.8
3.5
%
0.7
1.8
0.93
11
39
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
44
2.29
1.53
1.2
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
15
3.35
1.52
4.4
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
15
3.35
1.52
4.4
1.7
—
—
—
0
0
(3013512) EKG study
93
738
1.30
1.52
3.0
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
79
1.92
1.50
1.7
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
227
1.52
1.49
2.0
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
45
319
1.44
1.48
1.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
37
2.45
1.48
1.4
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
408
3784
1.19
1.46
3.2
2.5
mmol/l
1.2
1.1
1.78
390
3573
(3037121) Protein [Mass/volume] in Urine
33
221
1.52
1.43
5.5
6.0
g/l
0.2
0.3
0.23
23
152
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
40
2.27
1.40
1.1
1.4
nmol/l
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
14
74
1.91
1.40
1.1
2.1
mg/l
8.5
8.6
0.02
14
68
(3021879) Hepatitis B virus core Ab [Presence] in Serum
87
693
1.29
1.39
1.6
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
24
150
1.62
1.39
1.4
3.0
mg/l
471.5
436.1
0.12
24
141
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
231
1.50
1.39
1.2
1.2
—
—
—
0
0
(4010399)
35
240
1.48
1.37
1.5
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
41
2.21
1.37
1.1
1.3
—
—
—
0
0
(4094501)
9
41
2.21
1.37
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
17
2.95
1.36
1.0
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
117
971
1.25
1.35
2.8
2.3
ng/l
42.4
42.3
0.00
53
352
(40768797) Stomach Pathology biopsy report
59
449
1.34
1.31
1.2
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
115
956
1.24
1.31
2.4
2.9
mg/l
2.4
1.0
0.58
76
625
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
43
2.11
1.30
1.3
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
245
2195
1.18
1.28
4.5
4.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
35
2.30
1.27
1.5
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
108
895
1.24
1.26
1.6
1.6
%
1.5
1.4
1.05
97
821
(3014111) Lactate [Moles/volume] in Serum or Plasma
46
339
1.38
1.25
10.5
8.2
mmol/l
1.6
1.3
0.61
39
321
(3051651) Icteric interference index of Serum or Plasma
9
45
2.01
1.23
5.1
4.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
45
2.01
1.23
1.3
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
375
3487
1.16
1.20
5.4
3.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
38
2.12
1.18
1.9
2.2
—
—
—
0
0
(4268621)
12
64
1.89
1.18
2.5
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
79
1.79
1.17
6.7
13.8
u/ml
0.3
0.3
—
9
50
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
182
1.50
1.17
1.4
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
26
174
1.51
1.17
6.2
3.0
ng/l
196.3
132.7
0.29
21
156
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
1.8
1.4
g/l
0.9
1.0
—
5
20
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
32
446
0.70
1.14
1.6
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
103
1.67
1.13
1.4
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
111
1.64
1.13
1.3
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
127
1.59
1.12
4.4
3.3
—
—
—
0
0
(3015736) pH of Urine
222
1994
1.17
1.10
3.8
2.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
428
4035
1.16
1.10
3.5
2.7
mmol/l
2.7
2.7
0.09
408
3781
(3045142) Bone marrow Pathology biopsy report
7
31
2.27
1.10
1.6
1.6
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
31
2.27
1.10
2.0
1.8
—
1224630.0
—
0
5
(3004119) Hemoglobin [Mass/volume] in Venous blood
28
194
1.46
1.08
4.4
5.9
g/l
132.8
131.6
0.12
28
187
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
424
3998
1.16
1.08
3.4
2.7
mmol/l
1.4
1.4
0.24
404
3773
(3020891) Body temperature
16
97
1.66
1.07
1.8
5.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
336
0.67
1.07
1.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
31
220
1.43
1.06
2.1
1.8
u/ml
90.2
100.5
—
5
24
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
109
923
1.21
1.06
1.8
1.6
mmol/l
1.5
1.3
1.26
100
835
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
170
1.49
1.06
1.2
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
187
1.46
1.05
1.4
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
22
2.28
1.03
3.4
1.3
—
23.3
—
0
7
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
427
4038
1.15
1.02
3.5
2.7
mmol/l
4.5
4.5
0.01
407
3819
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
48
1.89
1.00
2.1
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
27
191
1.43
0.96
1.4
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
59
728
0.79
0.94
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
38
495
0.75
0.92
1.4
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
4.0
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
119
1.53
0.89
3.1
1.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
43
1.87
0.87
1.4
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
123
1076
1.17
0.85
1.5
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
80
1.64
0.85
2.4
1.8
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
31
1.94
0.84
4.2
6.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
40
310
1.31
0.84
1.7
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
32
1.88
0.82
2.2
3.1
u/ml
585.8
807.5
—
6
32
(3044290) Cell count panel - Cerebral spinal fluid
19
130
1.47
0.81
1.5
3.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
270
2506
1.13
0.81
4.2
3.0
estimate
0.0
0.0
0.00
60
515
(3001122) Ferritin [Mass/volume] in Serum or Plasma
316
2961
1.12
0.80
3.8
3.0
ug/l
66.0
55.8
0.59
288
2780
(3048929) Epstein Barr virus Ab [Presence] in Serum
73
613
1.21
0.80
1.6
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
114
1.50
0.80
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
39
304
1.30
0.80
1.8
1.6
u/ml
200.6
200.7
0.00
23
161
(3014007) Fractional oxyhemoglobin in Arterial blood
22
156
1.42
0.79
17.1
11.7
%
93.9
95.2
0.23
22
156
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
33
1.83
0.79
1.7
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
66
1.68
0.79
1.4
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
53
1.71
0.75
5.2
4.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
71
599
1.21
0.75
3.1
2.9
ng/l
191.5
1003.6
1.80
33
276
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
22
158
1.41
0.75
17.1
11.6
%
0.6
0.7
1.03
22
158
(3034770) Mitochondria Ab [Titer] in Serum
22
158
1.41
0.75
1.7
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
75
1.61
0.75
2.5
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
267
2486
1.12
0.75
4.3
3.0
estimate
0.0
0.0
0.00
59
504
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
84
1.56
0.72
1.0
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
68
1.63
0.72
2.3
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
40
1.76
0.71
1.3
3.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
40
1.76
0.71
1.3
3.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
45
551
0.80
0.70
1.4
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
303
1.27
0.68
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
147
1328
1.14
0.68
4.7
3.1
estimate
0.0
0.0
0.80
59
517
(3020393) Adenovirus Ag [Presence] in Stool
7
43
1.63
0.67
2.3
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
32
405
0.78
0.67
1.2
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
28
1.79
0.66
1.8
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
88
1004
0.86
0.66
1.5
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
31
242
1.29
0.65
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
332
1.25
0.65
4.8
4.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
62
1.62
0.65
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
120
1.43
0.65
2.6
1.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
29
1.73
0.64
2.2
2.2
mmol/l
4.0
3.9
—
5
29
(3035285) Chloride [Moles/volume] in Venous blood
5
29
1.73
0.64
2.2
2.2
mmol/l
107.8
106.4
—
5
29
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
268
0.74
0.63
1.3
1.6
mg/l
3.7
4.0
0.08
12
172
(3011397) Hemoglobin [Presence] in Urine by Test strip
131
1181
1.13
0.63
4.1
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
265
2488
1.11
0.62
5.8
4.2
estimate
0.0
0.0
0.00
60
531
(4034850)
6
101
0.59
0.62
3.8
6.5
—
—
—
0
0
(3002256) Pathology report gross observation
50
417
1.21
0.62
1.3
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
54
638
0.83
0.61
1.4
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
50
1.61
0.61
1.0
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
19
139
1.38
0.61
1.3
3.0
mmol/l
4.0
3.5
1.08
19
130
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
174
1.33
0.60
1.1
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(4198724)
15
105
1.44
0.60
2.9
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
51
428
1.21
0.60
1.6
1.6
nmol/l
1018.5
1100.4
0.32
45
331
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.59
3.6
1.5
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
11
73
1.52
0.56
1.8
1.4
nmol/l
60.5
38.3
0.72
11
67
(4035726)
30
240
1.26
0.54
1.6
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
12
82
1.47
0.54
1.5
1.6
mmol/l
5.2
6.9
—
6
51
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
38
1.58
0.54
1.2
2.0
g/l
3.0
3.1
—
6
33
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
350
3348
1.09
0.54
4.2
3.2
u/l
34.1
28.5
1.11
335
3211
(1761482) Bacteria [#/volume] in Urine by Culture
9
61
1.48
0.54
2.2
2.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
38
457
0.82
0.53
1.8
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
91
1.44
0.53
2.4
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.54
0.53
1.2
1.9
g/l
7.2
7.2
—
6
33
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.54
0.53
1.2
1.9
g/l
4.1
3.5
—
6
33
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.54
0.53
1.2
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
131
1196
1.12
0.52
2.1
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
73
826
0.87
0.51
1.7
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
45
1.56
0.49
3.4
1.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
45
1.56
0.49
1.0
1.0
%
96.6
87.2
—
7
45
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
45
1.56
0.49
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
128
1.34
0.48
2.6
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
153
0.71
0.46
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
120
0.66
0.46
2.4
2.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
85
0.59
0.45
1.0
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
78
870
0.88
0.45
1.7
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
140
1295
1.10
0.45
6.8
4.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
112
1.35
0.45
1.8
1.6
—
—
—
0
0
(4062490)
10
69
1.46
0.44
1.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
155
1442
1.10
0.44
3.7
2.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
39
331
1.19
0.44
1.1
1.2
u/ml
8.1
8.3
0.02
24
232
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
70
623
1.14
0.43
1.1
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
52
453
1.16
0.43
3.1
2.3
u/l
29.6
141.0
0.52
43
375
(3020491) Glucose [Moles/volume] in Blood
5
31
1.62
0.43
1.4
1.6
mmol/l
7.0
5.7
—
5
25
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
2.6
2.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
87
1.39
0.42
2.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
80
886
0.89
0.42
1.7
2.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
96
1.36
0.41
1.4
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
0
15
0.00
0.41
0.0
5.9
—
7.4
—
0
5
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
127
1175
1.10
0.41
3.8
2.9
kg/l
1.0
1.0
1.82
22
168
(4281824)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
282
0.81
0.41
1.4
1.4
—
—
—
0
0
(4027681)
8
59
1.36
0.41
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
15
114
1.32
0.41
1.8
1.5
ug/l
0.3
0.5
—
8
38
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
149
0.73
0.40
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
80
883
0.89
0.40
1.7
2.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
5.5
—
0
13
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
89
1.35
0.38
1.3
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
112
0.71
0.37
1.1
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
37
1.35
0.37
1.4
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
46
403
1.15
0.37
1.9
2.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
80
877
0.90
0.36
1.7
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
25
298
0.83
0.35
1.9
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
264
1.18
0.35
4.7
3.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
66
596
1.12
0.34
2.0
2.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
286
0.83
0.34
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
145
1.25
0.34
3.8
1.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
17
136
1.26
0.34
1.5
1.7
mmol/l
7.3
7.1
0.10
11
75
(3011648) Oxygen content in Venous blood
6
45
1.34
0.34
7.2
10.5
%
14.0
12.1
—
6
45
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
45
1.34
0.34
1.0
1.1
mg/l
257.0
306.6
—
6
39
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
144
0.76
0.33
2.4
2.0
—
—
—
0
0
(1002224) Polysomnography panel
19
155
1.23
0.32
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
1.6
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
34
389
0.87
0.31
1.9
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
68
744
0.90
0.31
1.2
1.2
iu/ml
13.0
17.3
0.65
17
185
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
53
1.32
0.31
1.6
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
54
1.30
0.30
3.0
4.1
umol/l
21.1
25.5
—
7
54
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
151
1429
1.07
0.30
2.5
2.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
20
166
1.21
0.30
1.3
1.2
—
1.3
—
0
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
308
1.14
0.28
1.7
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
260
2510
1.06
0.28
2.6
2.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
85
1.30
0.28
2.1
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
62
1.29
0.28
1.3
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
44
394
1.12
0.28
1.3
1.3
miu/ml
204.0
253.5
0.42
24
197
(3035933) Granulocytes/100 leukocytes in Blood
8
63
1.27
0.28
1.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
63
1.27
0.28
1.3
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
8
63
1.27
0.28
1.6
5.1
mmol/l
3.8
3.9
—
8
56
(3014051) Protein [Presence] in Urine by Test strip
9
117
0.77
0.27
2.0
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
65
1.23
0.27
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
225
1.16
0.26
1.3
1.3
—
—
—
0
0
(44806118)
10
77
1.30
0.26
2.0
1.8
—
—
—
0
0
(44790047)
10
77
1.30
0.26
2.0
1.8
—
—
—
0
0
(44790049)
10
77
1.30
0.26
2.0
1.8
—
—
—
0
0
(44790048)
10
77
1.30
0.26
2.0
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
203
0.83
0.26
1.6
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
195
1875
1.06
0.24
4.3
2.9
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
222
0.85
0.23
1.1
1.1
u/ml
7.7
5.7
0.22
11
108
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
143
1.19
0.23
1.2
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
36
323
1.12
0.23
1.1
1.2
u/ml
2.6
1.3
0.64
22
193
(40768804) Tissue Pathology biopsy report
151
1444
1.06
0.23
1.9
1.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
97
1.24
0.23
1.2
1.3
—
1.4
—
0
8
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
219
2264
0.95
0.22
2.9
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
200
1930
1.05
0.22
2.0
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
41
372
1.11
0.22
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
41
372
1.11
0.22
1.5
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
41
1.22
0.22
1.6
1.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
16
135
1.19
0.21
2.0
2.4
nmol/l
0.8
0.6
0.27
16
114
(3009445) Proteinase 3 Ab [Units/volume] in Serum
21
182
1.16
0.21
1.4
1.4
—
9.0
—
0
8
(3034274) Bile acid [Moles/volume] in Serum --fasting
31
277
1.12
0.21
2.6
3.2
umol/l
4.4
6.4
1.01
22
219
(40761536) Microorganisms panel - Urine sediment
55
508
1.09
0.21
4.2
3.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
11
0.00
0.21
0.0
1.2
—
506.9
—
0
11
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
11.9
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
6.5
—
0
12
(3007463) Buprenorphine [Presence] in Urine
0
13
0.00
0.21
0.0
3.9
—
—
—
0
0
(4133840)
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
80
1.25
0.20
1.6
4.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
3.5
—
120.6
—
0
14
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
65
695
0.93
0.20
1.2
1.2
u/ml
15.8
7.8
0.25
20
250
(3035320) C reactive protein [Mass/volume] in Body fluid
6
53
1.13
0.18
1.7
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
204
2102
0.96
0.18
2.5
2.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
166
1.15
0.18
1.5
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
1.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
41
378
1.09
0.17
1.6
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
33
301
1.10
0.17
2.2
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
203
2088
0.96
0.17
1.7
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
63
1.11
0.17
1.7
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
66
0.76
0.17
1.6
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
70
0.71
0.16
1.2
1.6
—
—
—
0
0
(44813793)
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
20
177
1.13
0.16
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
147
1519
0.96
0.15
2.1
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
30
274
1.10
0.15
2.2
2.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
78
1.16
0.15
7.8
1.4
%
13.3
12.8
—
9
78
(3018405) Lactate [Moles/volume] in Arterial blood
9
78
1.16
0.15
1.8
5.3
mmol/l
1.3
1.5
—
9
78
(3000492) Spirometry study
52
489
1.07
0.14
1.5
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
93
1.19
0.14
1.7
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
89
0.78
0.14
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
183
1782
1.04
0.14
2.0
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
128
0.86
0.13
2.4
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
36
335
1.08
0.13
4.1
2.4
%
30.7
32.6
0.49
27
246
(3023511) Choriogonadotropin [Units/volume] in Urine
46
434
1.06
0.12
1.5
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
21
191
1.10
0.12
3.3
1.5
g/l
1.2
1.2
0.09
21
180
(3017732) Neutrophils [#/volume] in Blood
34
318
1.07
0.11
3.6
1.9
e9/l
4.6
4.3
0.38
28
285
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
74
768
0.96
0.10
2.9
2.4
u/l
6565.6
5883.6
0.09
29
295
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
222
1.08
0.10
1.3
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
15
135
1.11
0.09
1.3
1.1
iu/ml
173.0
233.4
—
5
53
(3045414) Leukocytes [Presence] in Urine
22
203
1.09
0.09
2.0
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
10
114
0.88
0.09
1.6
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
563
5661
0.97
0.09
4.4
4.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
59
567
1.04
0.09
1.3
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
19
175
1.09
0.08
1.4
2.0
u/ml
22.9
43.7
1.05
19
168
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
65
0.77
0.08
1.8
2.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
67
1.05
0.08
1.6
3.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
67
1.05
0.08
1.3
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
77
1.04
0.07
2.8
1.8
ug/l
0.4
1.6
—
8
66
(3025130) Human papilloma virus identified in Specimen
9
86
1.05
0.07
1.7
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
94
0.85
0.06
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
33
316
1.05
0.05
1.1
1.2
u/ml
13.7
3.3
—
6
87
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
256
2536
1.01
0.05
2.3
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
38
367
1.04
0.04
1.1
1.2
u/ml
6.4
2.9
0.38
21
197
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
170
1.06
0.04
1.4
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
20
190
1.05
0.04
3.4
1.5
g/l
0.2
0.2
0.05
20
180
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
32
331
0.97
0.03
1.3
1.2
—
43.3
—
0
13
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
181
1.05
0.03
1.2
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
11
118
0.93
0.03
1.1
1.2
—
29.1
—
0
9
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
48
472
1.02
0.01
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
48
472
1.02
0.01
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
48
472
1.02
0.01
1.5
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
94
1.06
0.01
6.5
7.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
154
1.04
0.00
1.6
1.9
iu/l
3.4
6.1
—
5
60
(3002523) Influenza virus A Ag [Presence] in Specimen
16
166
0.96
0.00
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
165
0.97
0.00
1.1
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
17
166
1.02
0.00
7.5
2.6
e6/l
0.3
0.2
0.47
17
156
(3019225) pH of Specimen
27
265
1.02
0.00
4.5
4.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
204
0.98
0.00
1.9
1.6
iu/ml
0.1
0.3
—
5
42
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
13
133
0.98
0.00
1.2
1.3
—
64.5
—
0
9
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
27
266
1.02
0.00
1.9
2.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
48
475
1.01
0.00
1.5
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
173
0.98
0.00
2.2
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
52
525
0.99
0.00
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
108
1.02
0.00
1.7
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
75
746
1.01
0.00
1.5
1.5
titre
280.0
565.6
1.48
14
115
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
149
1495
1.00
0.00
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
58
581
1.00
0.00
1.8
2.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
17.9
—
0
7
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
3.7
—
0
6
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
3.0
—
0.8
—
0
5
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
52
0.96
0.00
1.6
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
66
0.91
0.00
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
67
0.89
0.00
1.3
1.1
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
5
0.00
0.00
0.0
3.0
—
17.0
—
0
5
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
0.5
—
0
5
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
67
0.89
0.00
1.3
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.1
—
0
5
(3019230) Fractional oxyhemoglobin in Venous blood
8
79
1.01
0.00
6.5
7.3
%
78.6
66.5
—
8
79
(1001926) Buprenorphine [Presence] in Urine by Screen method
71
710
1.00
0.00
1.6
2.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
84
0.95
0.00
1.3
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
15.4
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
67
0.89
0.00
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
65
0.92
0.00
1.2
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
200
1.00
0.00
1.1
1.1
u/ml
18.6
8.1
—
7
107
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
49
1.02
0.00
1.6
4.6
—
39.3
—
0
6
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
9
97
0.93
0.00
1.4
1.3
pmol/l
34.6
44.7
—
9
92
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
66
0.91
0.00
1.3
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_DISPUB_ALL – Disorders of puberty, all

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).